Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04615637
Other study ID # 69HCL20_0191
Secondary ID 2020-A00634-35
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2021
Est. completion date July 1, 2023

Study information

Verified date February 2021
Source Hospices Civils de Lyon
Contact Julien JUNG, MD
Phone 04.72.35.79.00
Email julien.jung@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our goal is to perform a first evaluation of the capabilities of a new generation of non-invasive magnetoencephalography sensors (OPM He4) to record brain magnetic activities. The investigator will record 1) normal subjects stimulated with visual, auditory, somesthesic and motor stimuli and 2) epileptic patient. The investigator will compare the signal to noise ratio of the normal or pathological activities between classical MEG sensors and our OPM He4 prototype.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 45
Est. completion date July 1, 2023
Est. primary completion date July 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: Volunteers: - Age 18+ - Right handed - Medical insurance - Strongly motivated to participate to the study - Signed informed consent for the study - No previous neurology or psychiatric pathologies - No major cognitive deficit and able to understand the instructions Patients: - Age 18+ - Right handed - Medical insurance - Strongly motivated to participate to the study - Signed informed consent for the study - No previous neurology or psychiatric pathologies (except epilepsy) - Epilepsy evolving during at least two years - No major cognitive deficit and able to understand the instructions Exclusion Criteria: Volunteers: - Age < 18 years or > 60 - previous neurology or psychiatric pathologies - Child bearing women - Subject having one of the following mettalic parts : - (pacemaker, implentable pump, neurosimulator, chochlear implant, auditory prothesis, mettalic prothesis, intracerebral clip, implantable defibrilator, any mettalic parts in the brain or upper part of the body, ventriculoperitoneal valve) - Claustrophobia Woman with a positive pregnancy test during the inclusion. Patients: Age < 18 years or > 60 - previous neurology or psychiatric pathologies except epilepsy - Child bearing women - Subject having one of the following mettalic parts : - (pacemaker, implentable pump, neurosimulator, chochlear implant, auditory prothesis, mettalic prothesis, intracerebral clip, implantable defibrilator, any mettalic parts in the brain or upper part of the body, ventriculoperitoneal valve) - Claustrophobia Woman with a positive pregnancy test during the inclusion.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
MEG recordings
Classical MEG recordings (patient at rest, normal subjects stimulated with visual, motor, somesthesic and auditory stimuli). MEG recordings with our OPM He4 prototype (patient at rest, normal subjects stimulated with visual, motor, somesthesic and auditory stimuli).

Locations

Country Name City State
France Hospices Civils de Lyon Bron

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Signal to Noise Ratio of the recorded brain activities Volunteers: The signal to noise ratio of normal brain activity following a stimulus will be computed with respect to the pre-stimulus baseline -100ms to -10 ms.
Epileptic patient: The signal to noise ratio of abnormal epileptic brain activity will be computed with respect to a 100 ms baseline not containing any abnormal activity.
1 month
Secondary Signal to Noise Ratio of pre-frontal auditory activity evaluate the capacities of MPO to record pre-frontal auditory activities which are not recorded by classical MEG. EEG will be the reference one month
Secondary Signal to Noise Ratio of high frequency epileptic activity evaluate the capacities of our MPO to record high frequency epileptic signal which are not recorded by current generation of MPO one month.
Secondary Comfort of the subject during the MPO He4 recordings for epileptic patient through a short verbal questionary The evaluation will be done verbally through a short questionary. This questionary evaluates the overall comfort of the MPO system with two questions: 1) An evaluation of the overall comfort thanks to a scale with five steps from very uncomfortable to very comfortable and 2) A comparison with the classical MEG system thanks to a 5 steps scale from much less comfortable than the classical MEG system to much more comfortable. 5 minutes after the end the recording session
Secondary Comfort of the subject during the MPO He4 recordings for volunteers through a short verbal questionary The evaluation will be done verbally through a short questionary. This questionary evaluates the overall comfort of the MPO system with two questions: 1) An evaluation of the overall comfort thanks to a scale with five steps from very uncomfortable to very comfortable and 2) A comparison with the classical MEG system thanks to a 5 steps scale from much less comfortable than the classical MEG system to much more comfortable. 5 minutes after the end of each recording session